Bacterial Membrane Proteins in Gram-Negative Sepsis
Project Number5R01GM059694-07
Contact PI/Project LeaderWARREN, H SHAW
Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
DESCRIPTION (provided by applicant):
During infection, membrane components are shed from bacteria in complexes that include LPS and two bacterial membrane lipoproteins: murein lipoprotein (MLP), and peptidoglycans associated lipoprotein (PAL). This renewal proposal seeks to study the physical interactions that each of these bacterial membrane components have with each other and with host lipoproteins, and the relative contribution of each in activation of cellular and systemic inflammatory responses that are mediated through Toll-like receptors (TLRs). Our central hypothesis is that MLP and PAL contribute to the pathogenesis of sepsis, and that their activity in vivo may be altered by interactions with each other, with LPS, and with host proteins and lipoproteins. Whereas most previous work has studied chemically purified or synthetic TLR agonists, this work will study natural forms of MLP and PAL wherever possible. The first specific aim is to study the kinetics of release of MLP and PAL from the bacterial cell wall into bacterial membrane complexes and into low density forms in serum. In vitro studies will utilize human serum. In vivo studies will be performed in two models of infection in mice: peritoneal E. coli infection
and cecal ligation and puncture. The physical association of MLP and PAL with subsets of lipoprotein particles containing LPS and apoA 1 and the distribution of MLP and PAL in organs and cells in tissues will be studied over time. The second specific aim is to compare the effects of serum released forms of MLP and PAL with chemically purified forms of each in vitro and in vivo. Effects will be evaluated using both macrophages and endothelial cells because these cells integrate the inflammaory response in sepsis. Bacterial strains deficient in MLP and PAL, and mice deficient in TLR2 and TLR4, will be used to distinguish the contributions of cellular activation by each bacterial lipoprotein and by LPS. Our third specific aim is to study the effect of anti-MLP IgG on the processes above and on survival in the two models. The experiments are designed to evaluate the importance that physiologically relevant forms of MLP and PAL play in the pathophysiology of sepsis during infection.
No Sub Projects information available for 5R01GM059694-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM059694-07
Patents
No Patents information available for 5R01GM059694-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM059694-07
Clinical Studies
No Clinical Studies information available for 5R01GM059694-07
News and More
Related News Releases
No news release information available for 5R01GM059694-07
History
No Historical information available for 5R01GM059694-07
Similar Projects
No Similar Projects information available for 5R01GM059694-07